Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nucleus Network

Nucleus Network?uq=w9if130k
2003 FOUNDED
PRIVATE STATUS
71-80 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of medical research and education precinct intended for the conduct of early phase clinical trials. The company is an 80-bed clinical trials facility intended for biotechnology and pharmaceutical clients, enabling an extensive experience evaluating new therapeutic treatments including vaccines and devices in both healthy volunteer and patient populations for a variety of early-stage clinical trials.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 5th Floor, Burnet Tower, AMREP Precinct
  • 89 Commercial Road
  • Melbourne, Victoria 3004
  • Australia

+61 (03) 0000 0000

Nucleus Network Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Nucleus Network‘s full profile, request access.

Request full access to PitchBook

Nucleus Network Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Nucleus Network‘s full profile, request access.

Request full access to PitchBook

Nucleus Network Executive Team (1)

Name Title Board
Seat
Contact
Info
Cameron Johnson Managing Director